Westlake Chemical (WLK) Reports Q2 Loss, Lags Revenue Estimates

05.08.25 13:45 Uhr

Werte in diesem Artikel

Westlake Chemical (WLK) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of $0.06. This compares to earnings of $2.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -250.00%. A quarter ago, it was expected that this chemical company would post earnings of $0.7 per share when it actually produced a loss of $0.31, delivering a surprise of -144.29%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Westlake, which belongs to the Zacks Chemical - Plastic industry, posted revenues of $2.95 billion for the quarter ended June 2025, missing the Zacks Consensus Estimate by 2.84%. This compares to year-ago revenues of $3.21 billion. The company has not been able to beat consensus revenue estimates over the last four quarters.The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.Westlake shares have lost about 33.5% since the beginning of the year versus the S&P 500's gain of 7.6%.What's Next for Westlake?While Westlake has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.Ahead of this earnings release, the estimate revisions trend for Westlake was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.75 on $3.06 billion in revenues for the coming quarter and $0.86 on $11.79 billion in revenues for the current fiscal year.Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Plastic is currently in the bottom 1% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.One other stock from the broader Zacks Basic Materials sector, Mativ Holdings (MATV), is yet to report results for the quarter ended June 2025. The results are expected to be released on August 6.This paper and reconstituted tobacco company is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents a year-over-year change of -47.1%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.Mativ Holdings' revenues are expected to be $505 million, down 3.6% from the year-ago quarter.Should You Invest in Westlake Corp. (WLK)?Before you invest in Westlake Corp. (WLK), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Westlake Corp. (WLK): Free Stock Analysis Report Mativ Holdings, Inc. (MATV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Q2 und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Q2

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q2

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Westlake Chemical Corp.

Wer­bung

Analysen zu Westlake Chemical Corp.

DatumRatingAnalyst
02.07.2019Westlake Chemical Equal WeightBarclays Capital
06.05.2019Westlake Chemical Market PerformCowen and Company, LLC
05.04.2019Westlake Chemical BuyCascend Securities
25.02.2019Westlake Chemical Market PerformCowen and Company, LLC
06.02.2019Westlake Chemical Market PerformCowen and Company, LLC
DatumRatingAnalyst
05.04.2019Westlake Chemical BuyCascend Securities
11.05.2018Westlake Chemical OutperformCowen and Company, LLC
29.03.2018Westlake Chemical Market PerformBMO Capital Markets
09.11.2017Westlake Chemical OutperformRBC Capital Markets
10.10.2017Westlake Chemical OutperformCowen and Company, LLC
DatumRatingAnalyst
02.07.2019Westlake Chemical Equal WeightBarclays Capital
06.05.2019Westlake Chemical Market PerformCowen and Company, LLC
25.02.2019Westlake Chemical Market PerformCowen and Company, LLC
06.02.2019Westlake Chemical Market PerformCowen and Company, LLC
11.12.2018Westlake Chemical Market PerformCowen and Company, LLC
DatumRatingAnalyst
27.08.2012Westlake Chemical sellUBS AG
30.03.2005Update Westlake Chemical Corp.: UnderweightLehman Brothers

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Westlake Chemical Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen